3,881
edits
Changes
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 13:01, 17 December 2023
, 13:01, 17 December 2023no edit summary
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+ WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
|-
|-
! Disease !! Page Type !! Author !! Date Assigned to Author !! Target Completion Date !! Author Content (Pending or Complete) !! Date Completed by Author !! Associate Editor !! Date of Last Editor Review !! Notes
!Disease (5th Edition)!!Page Type!!Author!!Date Assigned to Author!!Target Completion Date!!Author Content (Pending or Complete)!!Date Completed by Author!!Associate Editor!!Date of Last Editor Review
!Correlated Prior Disease Name (4th Edition)!!Notes
|-
|-
| Clonal haematopoiesis || Disease || || || || || || FQR || ||
|Clonal haematopoiesis||Disease|| || || || || ||Fabiola Quintero-Rivera (FQR)||
| ||
|-
|-
| Clonal cytopenias of undetermined significance || Disease || || || || || || FQR || ||
|Clonal cytopenias of undetermined significance||Disease|| || || || || ||FQR||
| ||
|-
|-
| Chronic myeloid leukaemia || Disease || Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) || || || || || FQR || ||
|Chronic myeloid leukaemia||Disease||Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)|| || || || ||FQR||
| ||
|-
|-
| Chronic neutrophilic leukaemia || Disease || Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally || || || || || FQR || ||
|Chronic neutrophilic leukaemia||Disease||Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally|| || || || ||FQR||
| ||
|-
|-
| Chronic eosinophilic leukaemia || Disease || Chelsea D. Kramish; Daynna J.Wolff Pending Review* || || || || || FQR || ||
|Chronic eosinophilic leukaemia||Disease||Chelsea D. Kramish; Daynna J.Wolff Pending Review*|| || || || ||FQR||
| ||
|-
|-
| Polycythaemia vera || Disease || Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center || || || || || FQR || ||
|Polycythaemia vera||Disease||Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center|| || || || ||FQR||
| ||
|-
|-
| Essential thrombocythaemia || Disease || Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN || || || || || FQR || ||
|Essential thrombocythaemia||Disease||Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN|| || || || ||FQR||
| ||
|-
|-
| Primary myelofibrosis || Disease || T. Niroshi Senaratne, UCLA || || || || || FQR || ||
|Primary myelofibrosis||Disease||T. Niroshi Senaratne, UCLA|| || || || ||FQR||
| ||
|-
|-
| Juvenile myelomonocytic leukaemia || Disease || '''Sarah Rapisardo, PhD, FACMG''' | Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories || || || || || FQR || ||
|Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' |Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories|| || || || ||FQR||
| ||
|-
|-
| Myeloproliferative neoplasm, NOS || Disease || Thomas Lee, MD, PhD, University of California, Los Angeles || || || || || FQR || ||
|Myeloproliferative neoplasm, NOS||Disease||Thomas Lee, MD, PhD, University of California, Los Angeles|| || || || ||FQR||
| ||
|-
|-
| Cutaneous mastocytosis || Disease || S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD || || || || || FQR || ||
|Cutaneous mastocytosis||Disease||S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD|| || || || ||FQR||
| ||
|-
|-
| Systemic mastocytosis || Disease || '''Abdullah Osme, MD,''' University Hospitals Cleveland Medical Center, Case Western Reserve University '''Shashi Shetty, Ph.D. FACMG, FCCMG,''' University Hospitals Cleveland Medical Center, Case Western Reserve University || || || || || FQR || ||
|Systemic mastocytosis||Disease||'''Abdullah Osme, MD,''' University Hospitals Cleveland Medical Center, Case Western Reserve University '''Shashi Shetty, Ph.D. FACMG, FCCMG,''' University Hospitals Cleveland Medical Center, Case Western Reserve University|| || || || ||FQR||
| ||
|-
|-
| Mast cell sarcoma || Disease || Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL || || || || || FQR || ||
|Mast cell sarcoma||Disease||Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL|| || || || ||FQR||
| ||
|-
|-
| Myelodysplastic neoplasm with low blasts and 5q deletion || Disease || Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG [[File:del(5)(q15q33).png|del(5)(q15q33)|322x322px]] || || || || || FQR || ||
|Myelodysplastic neoplasm with low blasts and 5q deletion||Disease|| || || || || ||FQR||
| ||
|-
|-
| Myelodysplastic neoplasm with low blasts and SF3B1 mutation || Disease || || || || || || FQR || ||
|Myelodysplastic neoplasm with low blasts and SF3B1 mutation||Disease|| || || || || ||FQR||
| ||
|-
|-
| Myelodysplastic neoplasm with biallelic TP53 inactivation || Disease || || || || || || FQR || ||
|Myelodysplastic neoplasm with biallelic TP53 inactivation||Disease|| || || || || ||FQR||
| ||
|-
|-
| Myelodysplastic neoplasm with low blasts || Disease || || || || || || FQR || ||
|Myelodysplastic neoplasm with low blasts||Disease|| || || || || ||FQR||
| ||
|-
|-
| Myelodysplastic neoplasm, hypoplastic || Disease || || || || || || FQR || ||
|Myelodysplastic neoplasm, hypoplastic||Disease|| || || || || ||FQR||
| ||
|-
|-
| Myelodysplastic neoplasm with increased blasts || Disease || Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. || || || || || FQR || ||
|Myelodysplastic neoplasm with increased blasts||Disease||Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.|| || || || ||FQR||
| ||
|-
|-
| Childhood myelodysplastic neoplasm with low blasts || Disease || Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. || || || || || FQR || ||
|Childhood myelodysplastic neoplasm with low blasts||Disease||Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.|| || || || ||FQR||
| ||
|-
|-
| Childhood myelodysplastic neoplasm with increased blasts || Disease || Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. || || || || || FQR || ||
|Childhood myelodysplastic neoplasm with increased blasts||Disease||Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.|| || || || ||FQR||
| ||
|-
|-
| Chronic myelomonocytic leukaemia || Disease || Linsheng Zhang, MD, PhD || || || || || FQR || ||
|Chronic myelomonocytic leukaemia||Disease||Linsheng Zhang, MD, PhD|| || || || ||FQR||
| ||
|-
|-
| Myelodysplastic/myeloproliferative neoplasm with neutrophilia || Disease || Linsheng Zhang, MD, PhD || || || || || FQR || ||
|Myelodysplastic/myeloproliferative neoplasm with neutrophilia||Disease||Linsheng Zhang, MD, PhD|| || || || ||FQR||
| ||
|-
|-
| Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis || Disease || Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine || || || || || FQR || ||
|Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis||Disease||Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine|| || || || ||FQR||
| ||
|-
|-
| Myelodysplastic/myeloproliferative neoplasm, NOS || Disease || Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia || || || || || FQR || ||
|Myelodysplastic/myeloproliferative neoplasm, NOS||Disease||Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia|| || || || ||FQR||
| ||
|-
|-
| Myeloid/lymphoid neoplasm with PDGFRA rearrangement || Disease || Jay Alden, DO || || || || || FQR || ||
|Myeloid/lymphoid neoplasm with PDGFRA rearrangement||Disease||Jay Alden, DO|| || || || ||FQR||
| ||
|-
|-
| Myeloid/lymphoid neoplasm with PDGFRB rearrangement || Disease || Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD || || || || || FQR || ||
|Myeloid/lymphoid neoplasm with PDGFRB rearrangement||Disease||Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD|| || || || ||FQR||
| ||
|-
|-
| Myeloid/lymphoid neoplasm with FGFR1 rearrangement || Disease || Yanna Ding, MD PhD || || || || || FQR || ||
|Myeloid/lymphoid neoplasm with FGFR1 rearrangement||Disease||Yanna Ding, MD PhD|| || || || ||FQR||
| ||
|-
|-
| Myeloid/lymphoid neoplasm with JAK2 rearrangement || Disease || Jessica Snider, M.D. and Daynna J. Wolff, PhD || || || || || FQR || ||
|Myeloid/lymphoid neoplasm with JAK2 rearrangement||Disease||Jessica Snider, M.D. and Daynna J. Wolff, PhD|| || || || ||FQR||
| ||
|-
|-
| Myeloid/lymphoid neoplasm with FLT3 rearrangement || Disease || || || || || || FQR || ||
|Myeloid/lymphoid neoplasm with FLT3 rearrangement||Disease|| || || || || ||FQR||
| ||
|-
|-
| Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion || Disease || || || || || || FQR || ||
|Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion||Disease|| || || || || ||FQR||
| ||
|-
|-
| Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes || Disease || || || || || || FQR || ||
|Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes||Disease|| || || || || ||FQR||
| ||
|-
|-
| Langerhans cell histiocytosis || Disease || Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland || || || || || GC || ||
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| Langerhans cell sarcoma || Disease || Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland || || || || || GC || ||
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| Indeterminate dendritic cell tumour || Disease || || || || || || GC || ||
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| Interdigitating dendritic cell sarcoma || Disease || || || || || || GC || ||
|Langerhans cell histiocytosis||Disease||Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland|| || || || ||GC||
| ||
|-
|-
| Juvenile xanthogranuloma || Disease || || || || || || GC || ||
|Langerhans cell sarcoma||Disease||Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland|| || || || ||GC||
| ||
|-
|-
| Erdheim-Chester disease || Disease || || || || || || GC || ||
|Indeterminate dendritic cell tumour||Disease|| || || || || ||GC||
| ||
|-
|-
| Rosai-Dorfman Disease || Disease || || || || || || GC || ||
|Interdigitating dendritic cell sarcoma||Disease|| || || || || ||GC||
| ||
|-
|-
| ALK-positive histiocytosis || Disease || || || || || || GC || ||
|Juvenile xanthogranuloma||Disease|| || || || || ||GC||
| ||
|-
|-
| Histiocytic sarcoma || Disease || Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic || || || || || GC || ||
|Erdheim-Chester disease||Disease|| || || || || ||GC||
| ||
|-
|-
| Reactive B-cell rich lymphoid proliferations that can mimic lymphoma || Disease || || || || || || GC || ||
|Rosai-Dorfman Disease||Disease|| || || || || ||GC||
| ||
|-
|-
| IgG4-related disease || Disease || || || || || || GC || ||
|ALK-positive histiocytosis||Disease|| || || || || ||GC||
| ||
|-
|-
| Unicentric Castleman disease || Disease || || || || || || GC || ||
|Histiocytic sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic|| || || || ||GC||
| ||
|-
|-
| Idiopathic multicentric Castleman disease || Disease || || || || || || GC || ||
|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| KSHV/HHV8-associated multicentric Castleman disease || Disease || Sudha Arumugam, MD || || || || || GC || ||
|IgG4-related disease||Disease|| || || || || ||GC||
| ||
|-
|-
| Diffuse large B-cell lymphoma, NOS || Disease || Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center || || || || || GC || ||
|Unicentric Castleman disease||Disease|| || || || || ||GC||
| ||
|-
|-
| T-cell/histiocyte-rich large B-cell lymphoma || Disease || || || || || || GC || ||
|Idiopathic multicentric Castleman disease||Disease|| || || || || ||GC||
| ||
|-
|-
| Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements || Disease || Kate Berry, MBBS, BBus (Hons), Pathology Queensland || || || || || GC || ||
|KSHV/HHV8-associated multicentric Castleman disease||Disease||Sudha Arumugam, MD|| || || || ||GC||
| ||
|-
|-
| ALK-positive large B-cell lymphoma || Disease || Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) || || || || || GC || ||
|Diffuse large B-cell lymphoma, NOS||Disease||Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center|| || || || ||GC||
| ||
|-
|-
| Large B-cell lymphoma with IRF4 rearrangement || Disease || *Afia Hasnain, MBBS, PhD || || || || || GC || ||
|T-cell/histiocyte-rich large B-cell lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| High grade B-cell lymphoma with 11q aberrations || Disease || Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina || || || || || GC || ||
|Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements||Disease||Kate Berry, MBBS, BBus (Hons), Pathology Queensland|| || || || ||GC||
| ||
|-
|-
| Lymphomatoid granulomatosis || Disease || || || || || || GC || ||
|ALK-positive large B-cell lymphoma||Disease||Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)|| || || || ||GC||
| ||
|-
|-
| EBV-positive diffuse large B-cell lymphoma || Disease || || || || || || GC || ||
|Large B-cell lymphoma with IRF4 rearrangement||Disease||*Afia Hasnain, MBBS, PhD|| || || || ||GC||
| ||
|-
|-
| Diffuse large B-cell lymphoma associated with chronic inflammation || Disease || || || || || || GC || ||
|High grade B-cell lymphoma with 11q aberrations||Disease||Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina|| || || || ||GC||
| ||
|-
|-
| Fibrin-associated large B-cell lymphoma || Disease || || || || || || GC || ||
|Lymphomatoid granulomatosis||Disease|| || || || || ||GC||
| ||
|-
|-
| Fluid overload-associated large B-cell lymphoma || Disease || || || || || || GC || ||
|EBV-positive diffuse large B-cell lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| Plasmablastic lymphoma || Disease || Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) || || || || || GC || ||
|Diffuse large B-cell lymphoma associated with chronic inflammation||Disease|| || || || || ||GC||
| ||
|-
|-
| Primary large B-cell lymphoma of immune-privileged sites || Disease || Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center || || || || || GC || ||
|Fibrin-associated large B-cell lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| Primary cutaneous diffuse large B-cell lymphoma, leg type || Disease || || || || || || GC || ||
|Fluid overload-associated large B-cell lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| Intravascular large B-cell lymphoma || Disease || Kate Berry, MBBS, BBus (Hons), Pathology Queensland || || || || || GC || ||
|Plasmablastic lymphoma||Disease||Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)|| || || || ||GC||
| ||
|-
|-
| Primary mediastinal large B-cell lymphoma || Disease || || || || || || GC || ||
|Primary large B-cell lymphoma of immune-privileged sites||Disease||Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center|| || || || ||GC||
| ||
|-
|-
| Mediastinal grey zone lymphoma || Disease || || || || || || GC || ||
|Primary cutaneous diffuse large B-cell lymphoma, leg type||Disease|| || || || || ||GC||
| ||
|-
|-
| High-grade B-cell lymphoma, NOS || Disease || Aiko Otsubo, PhD, Indiana University || || || || || GC || ||
|Intravascular large B-cell lymphoma||Disease||Kate Berry, MBBS, BBus (Hons), Pathology Queensland|| || || || ||GC||
| ||
|-
|-
| Burkitt lymphoma || Disease || Becky Leung, MBBS (Hons), BSc, Pathology Queensland || || || || || GC || ||
|Primary mediastinal large B-cell lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| Primary effusion lymphoma || Disease || || || || || || GC || ||
|Mediastinal grey zone lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| KSHV/HHV8-positive diffuse large B-cell lymphoma || Disease || || || || || || GC || ||
|High-grade B-cell lymphoma, NOS||Disease||Aiko Otsubo, PhD, Indiana University|| || || || ||GC||
| ||
|-
|-
| KSHV/HHV8-positive germinotropic lymphoproliferative disorder || Disease || || || || || || GC || ||
|Burkitt lymphoma||Disease||Becky Leung, MBBS (Hons), BSc, Pathology Queensland|| || || || ||GC||
| ||
|-
|-
| Hyperplasias arising in immune deficiency/dysregulation || Disease || || || || || || GC || ||
|Primary effusion lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation || Disease || Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) || || || || || GC || ||
|KSHV/HHV8-positive diffuse large B-cell lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| EBV-positive mucocutaneous ulcer || Disease || || || || || || GC || ||
|KSHV/HHV8-positive germinotropic lymphoproliferative disorder||Disease|| || || || || ||GC||
| ||
|-
|-
| Lymphomas arising in immune deficiency / dysregulation || Disease || || || || || || GC || ||
|Hyperplasias arising in immune deficiency/dysregulation||Disease|| || || || || ||GC||
| ||
|-
|-
| Inborn error of immunity-associated lymphoid proliferations and lymphomas || Disease || || || || || || GC || ||
|Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease||Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI)|| || || || ||GC||
| ||
|-
|-
| Classic Hodgkin lymphoma || Disease || Patricia V. Hernandez, M.D., Washington University School of Medicine || || || || || GC || ||
|EBV-positive mucocutaneous ulcer||Disease|| || || || || ||GC||
| ||
|-
|-
| Nodular lymphocyte predominant Hodgkin lymphoma || Disease || || || || || || GC || ||
|Lymphomas arising in immune deficiency / dysregulation||Disease|| || || || || ||GC||
| ||
|-
|-
| Acute promyelocytic leukaemia with PML::RARA fusion || Disease || Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. || || || || || JH_MS || ||
|Inborn error of immunity-associated lymphoid proliferations and lymphomas||Disease|| || || || || ||GC||
| ||
|-
|-
| Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion || Disease || Christine Bryke, MD<br>Beth Israel Deaconess Medical Center, Boston, MA || || || || || JH_MS || ||
|Classic Hodgkin lymphoma||Disease||Patricia V. Hernandez, M.D., Washington University School of Medicine|| || || || ||GC||
| ||
|-
|-
| Acute myeloid leukaemia with CBFB::MYH11 fusion || Disease || Christine Bryke, MD <br> Beth Israel Deaconess Medical Center, Boston, MA || || || || || JH_MS || ||
|Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC||
| ||
|-
|-
| Acute myeloid leukaemia with DEK::NUP214 fusion || Disease || Jennelle C. Hodge, PhD, FACMG [[File:T(6;9)(p23;q34).png]] || || || || || JH_MS || ||
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| Acute myeloid leukaemia with RBM15::MRTFA fusion || Disease || Jennelle C. Hodge, PhD, FACMG || || || || || JH_MS || ||
|Acute promyelocytic leukaemia with PML::RARA fusion||Disease||Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D.|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with BCR::ABL1 fusion || Disease || Kay Weng Choy MBBS, Monash Medical Centre || || || || || JH_MS || ||
|Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion||Disease||Christine Bryke, MD<br>Beth Israel Deaconess Medical Center, Boston, MA|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with KMT2A rearrangement || Disease || Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. || || || || || JH_MS || ||
|Acute myeloid leukaemia with CBFB::MYH11 fusion||Disease||Christine Bryke, MD <br> Beth Israel Deaconess Medical Center, Boston, MA|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with MECOM rearrangement || Disease || Gordana Raca MD PhD, University of Southern California, Los Angeles [[File:inv(3)(q21q26.2).png|inv(3)(q21q26.2)]] [[File:t(3;3)(q21;q26.2).png|t(3;3)(q21;q26.2)]] || || || || || JH_MS || ||
|Acute myeloid leukaemia with DEK::NUP214 fusion||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with NUP98 rearrangement || Disease || || || || || || JH_MS || ||
|Acute myeloid leukaemia with RBM15::MRTFA fusion||Disease||Jennelle C. Hodge, PhD, FACMG|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with NPM1 mutation || Disease || Xinjie Xu, PhD, FACMG || || || || || JH_MS || ||
|Acute myeloid leukaemia with BCR::ABL1 fusion||Disease||Kay Weng Choy MBBS, Monash Medical Centre|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with CEBPA mutation || Disease || Paul Defazio, MSc, Monash Health || || || || || JH_MS || ||
|Acute myeloid leukaemia with KMT2A rearrangement||Disease||Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D.|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia, myelodysplasia-related || Disease || Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR || || || || || JH_MS || ||
|Acute myeloid leukaemia with MECOM rearrangement||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with other defined genetic alterations || Disease || || || || || || JH_MS || ||
|Acute myeloid leukaemia with NUP98 rearrangement||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with minimal differentiation || Disease || Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine || || || || || JH_MS || ||
|Acute myeloid leukaemia with NPM1 mutation||Disease||Xinjie Xu, PhD, FACMG|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia without maturation || Disease || Jennelle C. Hodge, PhD, FACMG || || || || || JH_MS || ||
|Acute myeloid leukaemia with CEBPA mutation||Disease||Paul Defazio, MSc, Monash Health|| || || || ||JH_MS||
| ||
|-
|-
| Acute myeloid leukaemia with maturation || Disease || Jennelle C. Hodge, PhD, FACMG || || || || || JH_MS || ||
|Acute myeloid leukaemia, myelodysplasia-related||Disease||Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR|| || || || ||JH_MS||
| ||
|-
|-
| Acute basophilic leukaemia || Disease || Ashwini Yenamandra PhD FACMG || || || || || JH_MS || ||
|Acute myeloid leukaemia with other defined genetic alterations||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Acute myelomonocytic leukaemia || Disease || Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR || || || || || JH_MS || ||
|Acute myeloid leukaemia with minimal differentiation||Disease||Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine|| || || || ||JH_MS||
| ||
|-
|-
| Acute monocytic leukaemia || Disease || Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR || || || || || JH_MS || ||
|Acute myeloid leukaemia without maturation||Disease||Jennelle C. Hodge, PhD, FACMG|| || || || ||JH_MS||
| ||
|-
|-
| Acute erythroid leukaemia || Disease || Ashwini Yenamandra PhD FACMG || || || || || JH_MS || ||
|Acute myeloid leukaemia with maturation||Disease||Jennelle C. Hodge, PhD, FACMG|| || || || ||JH_MS||
| ||
|-
|-
| Acute megakaryoblastic leukaemia || Disease || Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR || || || || || JH_MS || ||
|Acute basophilic leukaemia||Disease||Ashwini Yenamandra PhD FACMG|| || || || ||JH_MS||
| ||
|-
|-
| Myeloid sarcoma || Disease || Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine || || || || || JH_MS || ||
|Acute myelomonocytic leukaemia||Disease||Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR|| || || || ||JH_MS||
| ||
|-
|-
| Myeloid neoplasm post cytotoxic therapy || Disease || Shawn A. Silver, DO, Shashi Shetty, Ph.D. || || || || || JH_MS || ||
|Acute monocytic leukaemia||Disease||Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR|| || || || ||JH_MS||
| ||
|-
|-
| Myeloid neoplasms associated with germline predisposition || Disease || || || || || || JH_MS || ||
|Acute erythroid leukaemia||Disease||Ashwini Yenamandra PhD FACMG|| || || || ||JH_MS||
| ||
|-
|-
| Myeloid proliferations associated with Down syndrome || Disease || Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO || || || || || JH_MS || ||
|Acute megakaryoblastic leukaemia||Disease||Fei Yang, MD, FACMG <br> Oregon Health & Science University, Portland, OR|| || || || ||JH_MS||
| ||
|-
|-
| Mixed-phenotype acute leukaemia with BCR::ABL1 fusion || Disease || Tracy Tucker, PhD, FCCMG || || || || || JH_MS || ||
|Myeloid sarcoma||Disease||Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine|| || || || ||JH_MS||
| ||
|-
|-
| Mixed-phenotype acute leukaemia with KMT2A rearrangement || Disease || Tracy Tucker, PhD, FCCMG || || || || || JH_MS || ||
|Myeloid neoplasm post cytotoxic therapy||Disease||Shawn A. Silver, DO, Shashi Shetty, Ph.D.|| || || || ||JH_MS||
| ||
|-
|-
| Acute leukaemia of ambiguous lineage with other defined genetic alterations || Disease || || || || || || JH_MS || ||
|Myeloid neoplasms associated with germline predisposition||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Mixed-phenotype acute leukaemia, B/myeloid || Disease || Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD || || || || || JH_MS || ||
|Myeloid proliferations associated with Down syndrome||Disease||Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO|| || || || ||JH_MS||
| ||
|-
|-
| Mixed-phenotype acute leukaemia, T/myeloid || Disease || Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine || || || || || JH_MS || ||
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| Mixed-phenotype acute leukaemia, rare types || Disease || Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina || || || || || JH_MS || ||
|Mixed-phenotype acute leukaemia with BCR::ABL1 fusion||Disease||Tracy Tucker, PhD, FCCMG|| || || || ||JH_MS||
| ||
|-
|-
| Acute leukaemia of ambiguous lineage, NOS || Disease || || || || || || JH_MS || ||
|Mixed-phenotype acute leukaemia with KMT2A rearrangement||Disease||Tracy Tucker, PhD, FCCMG|| || || || ||JH_MS||
| ||
|-
|-
| Acute undifferentiated leukaemia || Disease || Amelia Nakanishi, MD and Shashi Shetty, PhD || || || || || JH_MS || ||
|Acute leukaemia of ambiguous lineage with other defined genetic alterations||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm || Disease || || || || || || JH_MS || ||
|Mixed-phenotype acute leukaemia, B/myeloid||Disease||Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD|| || || || ||JH_MS||
| ||
|-
|-
| Blastic plasmacytoid dendritic cell neoplasm || Disease || Hao Liu, MD and Daynna J. Wolff, PhD || || || || || JH_MS || ||
|Mixed-phenotype acute leukaemia, T/myeloid||Disease||Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine|| || || || ||JH_MS||
| ||
|-
|-
| Monoclonal B-cell lymphocytosis || Disease || || || || || || SP || ||
|Mixed-phenotype acute leukaemia, rare types||Disease||Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina|| || || || ||JH_MS||
| ||
|-
|-
| Chronic lymphocytic leukaemia/small lymphocytic lymphoma || Disease || Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD || || || || || SP || ||
|Acute leukaemia of ambiguous lineage, NOS||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Hairy cell leukaemia || Disease || *Snehal Patel, MD, PhD || || || || || SP || ||
|Acute undifferentiated leukaemia||Disease||Amelia Nakanishi, MD and Shashi Shetty, PhD|| || || || ||JH_MS||
| ||
|-
|-
| Splenic marginal zone lymphoma || Disease || *Snehal Patel, MD, PhD || || || || || SP || ||
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| Splenic diffuse red pulp small B-cell lymphoma || Disease || *Snehal Patel, MD, PhD || || || || || SP || ||
|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm||Disease|| || || || || ||JH_MS||
| ||
|-
|-
| Splenic B-cell lymphoma/leukaemia with prominent nucleoli || Disease || *Snehal Patel, MD, PhD || || || || || SP || ||
|Blastic plasmacytoid dendritic cell neoplasm||Disease||Hao Liu, MD and Daynna J. Wolff, PhD|| || || || ||JH_MS||
| ||
|-
|-
| Lymphoplasmacytic lymphoma || Disease || Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) || || || || || SP || ||
|Monoclonal B-cell lymphocytosis||Disease|| || || || || ||SP||
| ||
|-
|-
| Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue || Disease || || || || || || SP || ||
|Chronic lymphocytic leukaemia/small lymphocytic lymphoma||Disease||Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD|| || || || ||SP||
| ||
|-
|-
| Primary cutaneous marginal zone lymphoma || Disease || || || || || || SP || ||
|Hairy cell leukaemia||Disease||*Snehal Patel, MD, PhD|| || || || ||SP||
| ||
|-
|-
| Nodal marginal zone lymphoma || Disease || Andrew Ly, DO and Shivani Golem, PhD, FACMG || || || || || SP || ||
|Splenic marginal zone lymphoma||Disease||*Snehal Patel, MD, PhD|| || || || ||SP||
| ||
|-
|-
| Paediatric nodal marginal zone lymphoma || Disease || * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD || || || || || SP || ||
|Splenic diffuse red pulp small B-cell lymphoma||Disease||*Snehal Patel, MD, PhD|| || || || ||SP||
| ||
|-
|-
| In situ follicular B-cell neoplasm || Disease || Rachel D. Burnside, PhD, MBA, FACMGG || || || || || SP || ||
|Splenic B-cell lymphoma/leukaemia with prominent nucleoli||Disease||*Snehal Patel, MD, PhD|| || || || ||SP||
| ||
|-
|-
| Follicular lymphoma || Disease || Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida || || || || || SP || ||
|Lymphoplasmacytic lymphoma||Disease||Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)|| || || || ||SP||
| ||
|-
|-
| Paediatric-type follicular lymphoma || Disease || *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG || || || || || SP || ||
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue||Disease|| || || || || ||SP||
| ||
|-
|-
| Duodenal-type follicular lymphoma || Disease || || || || || || SP || ||
|Primary cutaneous marginal zone lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| Primary cutaneous follicle centre lymphoma || Disease || Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG || || || || || SP || ||
|Nodal marginal zone lymphoma||Disease||Andrew Ly, DO and Shivani Golem, PhD, FACMG|| || || || ||SP||
| ||
|-
|-
| In situ mantle cell neoplasm || Disease || Rina Kansal, MD; Versiti Blood Center of Wisconsin || || || || || SP || ||
|Paediatric nodal marginal zone lymphoma||Disease||* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD|| || || || ||SP||
| ||
|-
|-
| Mantle cell lymphoma || Disease || * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas || || || || || SP || ||
|In situ follicular B-cell neoplasm||Disease||Rachel D. Burnside, PhD, MBA, FACMGG|| || || || ||SP||
| ||
|-
|-
| Leukaemic non-nodal mantle cell lymphoma || Disease || <br /> || || || || || SP || ||
|Follicular lymphoma||Disease||Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida|| || || || ||SP||
| ||
|-
|-
| Transformations of indolent B-cell lymphomas || Disease || || || || || || SP || ||
|Paediatric-type follicular lymphoma||Disease||*Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG|| || || || ||SP||
| ||
|-
|-
| Cold agglutinin disease || Disease || || || || || || SP || ||
|Duodenal-type follicular lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| IgM monoclonal gammopathy of undetermined significance || Disease || || || || || || SP || ||
|Primary cutaneous follicle centre lymphoma||Disease||Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG|| || || || ||SP||
| ||
|-
|-
| Non-IgM monoclonal gammopathy of undetermined significance || Disease || || || || || || SP || ||
|In situ mantle cell neoplasm||Disease||Rina Kansal, MD; Versiti Blood Center of Wisconsin|| || || || ||SP||
| ||
|-
|-
| Monoclonal gammopathy of renal significance || Disease || || || || || || SP || ||
|Mantle cell lymphoma||Disease||* Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas|| || || || ||SP||
| ||
|-
|-
| Immunoglobulin-related (AL) amyloidosis || Disease || Heather E. Williams, PhD, MS, PgD, ErCLG || || || || || SP || ||
|Leukaemic non-nodal mantle cell lymphoma||Disease||<br />|| || || || ||SP||
| ||
|-
|-
| Monoclonal immunoglobulin deposition disease || Disease || Chen Yang, MD, PhD, University of Michigan || || || || || SP || ||
|Transformations of indolent B-cell lymphomas||Disease|| || || || || ||SP||
| ||
|-
|-
| Mu heavy chain disease || Disease || || || || || || SP || ||
|Cold agglutinin disease||Disease|| || || || || ||SP||
| ||
|-
|-
| Gamma heavy chain disease || Disease || Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA || || || || || SP || ||
|IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SP||
| ||
|-
|-
| Alpha heavy chain disease || Disease || || || || || || SP || ||
|Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SP||
| ||
|-
|-
| Plasmacytoma || Disease || || || || || || SP || ||
|Monoclonal gammopathy of renal significance||Disease|| || || || || ||SP||
| ||
|-
|-
| Plasma cell myeloma / multiple myeloma || Disease || *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas || || || || || SP || ||
|Immunoglobulin-related (AL) amyloidosis||Disease||Heather E. Williams, PhD, MS, PgD, ErCLG|| || || || ||SP||
| ||
|-
|-
| Plasma cell neoplasms with associated paraneoplastic syndrome || Disease || Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD || || || || || SP || ||
|Monoclonal immunoglobulin deposition disease||Disease||Chen Yang, MD, PhD, University of Michigan|| || || || ||SP||
| ||
|-
|-
| Kikuchi-Fujimoto disease || Disease || || || || || || SP || ||
|Mu heavy chain disease||Disease|| || || || || ||SP||
| ||
|-
|-
| Autoimmune lymphoproliferative syndrome || Disease || || || || || || SP || ||
|Gamma heavy chain disease||Disease||Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA|| || || || ||SP||
| ||
|-
|-
| Indolent T-lymphoblastic proliferation || Disease || || || || || || SP || ||
|Alpha heavy chain disease||Disease|| || || || || ||SP||
| ||
|-
|-
| T-prolymphocytic leukaemia || Disease || || || || || || SP || ||
|Plasmacytoma||Disease|| || || || || ||SP||
| ||
|-
|-
| T-large granular lymphocytic leukaemia || Disease || *Michelle Don, MD, MS || || || || || SP || ||
|Plasma cell myeloma / multiple myeloma||Disease||*Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas|| || || || ||SP||
| ||
|-
|-
| NK-large granular lymphocytic leukaemia || Disease || Michelle Don, MD || || || || || SP || ||
|Plasma cell neoplasms with associated paraneoplastic syndrome||Disease||Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD|| || || || ||SP||
| ||
|-
|-
| Adult T-cell leukaemia/lymphoma || Disease || Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center || || || || || SP || ||
|Kikuchi-Fujimoto disease||Disease|| || || || || ||SP||
| ||
|-
|-
| Sezary syndrome || Disease || Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina || || || || || SP || ||
|Autoimmune lymphoproliferative syndrome||Disease|| || || || || ||SP||
| ||
|-
|-
| Aggressive NK-cell leukaemia || Disease || Shanelle De Lancy, MD, Shashirekha Shetty, PhD || || || || || SP || ||
|Indolent T-lymphoblastic proliferation||Disease|| || || || || ||SP||
| ||
|-
|-
| Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder || Disease || || || || || || SP || ||
|T-prolymphocytic leukaemia||Disease|| || || || || ||SP||
| ||
|-
|-
| Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder || Disease || || || || || || SP || ||
|T-large granular lymphocytic leukaemia||Disease||*Michelle Don, MD, MS|| || || || ||SP||
| ||
|-
|-
| Mycosis fungoides || Disease || Jane Scribner, MD and Daynna J. Wolff, PhD || || || || || SP || ||
|NK-large granular lymphocytic leukaemia||Disease||Michelle Don, MD|| || || || ||SP||
| ||
|-
|-
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis || Disease || || || || || || SP || ||
|Adult T-cell leukaemia/lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center|| || || || ||SP||
| ||
|-
|-
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma || Disease || Theresa Spivey, MD, Shashirekha Shetty, PhD || || || || || SP || ||
|Sezary syndrome||Disease||Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina|| || || || ||SP||
| ||
|-
|-
| Subcutaneous panniculitis-like T-cell lymphoma || Disease || || || || || || SP || ||
|Aggressive NK-cell leukaemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD|| || || || ||SP||
| ||
|-
|-
| Primary cutaneous gamma/delta T-cell lymphoma || Disease || || || || || || SP || ||
|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder||Disease|| || || || || ||SP||
| ||
|-
|-
| Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma || Disease || || || || || || SP || ||
|Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder||Disease|| || || || || ||SP||
| ||
|-
|-
| Primary cutaneous peripheral T-cell lymphoma, NOS || Disease || || || || || || SP || ||
|Mycosis fungoides||Disease||Jane Scribner, MD and Daynna J. Wolff, PhD|| || || || ||SP||
| ||
|-
|-
| Indolent T-cell lymphoma of the gastrointestinal tract || Disease || Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD || || || || || SP || ||
|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis||Disease|| || || || || ||SP||
| ||
|-
|-
| Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract || Disease || || || || || || SP || ||
|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD|| || || || ||SP||
| ||
|-
|-
| Enteropathy-associated T-cell lymphoma || Disease || *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD || || || || || SP || ||
|Subcutaneous panniculitis-like T-cell lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| Monomorphic epitheliotropic intestinal T-cell lymphoma || Disease || Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD || || || || || SP || ||
|Primary cutaneous gamma/delta T-cell lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| Intestinal T-cell lymphoma, NOS || Disease || Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) || || || || || SP || ||
|Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| Hepatosplenic T-cell lymphoma || Disease || *Michelle Don, MD, MS || || || || || SP || ||
|Primary cutaneous peripheral T-cell lymphoma, NOS||Disease|| || || || || ||SP||
| ||
|-
|-
| ALK-positive anaplastic large cell lymphoma || Disease || || || || || || SP || ||
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease||Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD|| || || || ||SP||
| ||
|-
|-
| ALK-negative anaplastic large cell lymphoma || Disease || Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA || || || || || SP || ||
|Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract||Disease|| || || || || ||SP||
| ||
|-
|-
| Breast implant-associated anaplastic large cell lymphoma || Disease || Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center || || || || || SP || ||
|Enteropathy-associated T-cell lymphoma||Disease||*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD|| || || || ||SP||
| ||
|-
|-
| Nodal TFH cell lymphoma, angioimmunoblastic-type || Disease || * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG || || || || || SP || ||
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease||Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD|| || || || ||SP||
| ||
|-
|-
| Nodal TFH cell lymphoma, follicular-type || Disease || || || || || || SP || ||
|Intestinal T-cell lymphoma, NOS||Disease||Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA)|| || || || ||SP||
| ||
|-
|-
| Nodal TFH cell lymphoma, NOS || Disease || Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD || || || || || SP || ||
|Hepatosplenic T-cell lymphoma||Disease||*Michelle Don, MD, MS|| || || || ||SP||
| ||
|-
|-
| Peripheral T-cell lymphoma, NOS || Disease || || || || || || SP || ||
|ALK-positive anaplastic large cell lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| EBV-positive nodal T- and NK-cell lymphoma || Disease || || || || || || SP || ||
|ALK-negative anaplastic large cell lymphoma||Disease||Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA|| || || || ||SP||
| ||
|-
|-
| Extranodal NK/T-cell lymphoma || Disease || || || || || || SP || ||
|Breast implant-associated anaplastic large cell lymphoma||Disease||Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center|| || || || ||SP||
| ||
|-
|-
| Severe mosquito bite allergy || Disease || || || || || || SP || ||
|Nodal TFH cell lymphoma, angioimmunoblastic-type||Disease||* Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG|| || || || ||SP||
| ||
|-
|-
| Hydroa vacciniforme lymphoproliferative disorder || Disease || || || || || || SP || ||
|Nodal TFH cell lymphoma, follicular-type||Disease|| || || || || ||SP||
| ||
|-
|-
| Systemic chronic active EBV disease || Disease || || || || || || SP || ||
|Nodal TFH cell lymphoma, NOS||Disease||Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD|| || || || ||SP||
| ||
|-
|-
| Systemic EBV-positive T-cell lymphoma of childhood || Disease || *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA || || || || || SP || ||
|Peripheral T-cell lymphoma, NOS||Disease|| || || || || ||SP||
| ||
|-
|-
| Follicular dendritic cell sarcoma || Disease || Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG || || || || || SP || ||
|EBV-positive nodal T- and NK-cell lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| EBV-positive inflammatory follicular dendritic cell sarcoma || Disease || || || || || || SP || ||
|Extranodal NK/T-cell lymphoma||Disease|| || || || || ||SP||
| ||
|-
|-
| Fibroblastic reticular cell tumour || Disease || || || || || || SP || ||
|Severe mosquito bite allergy||Disease|| || || || || ||SP||
| ||
|-
|-
| Intranodal palisaded myofibroblastoma || Disease || || || || || || SP || ||
|Hydroa vacciniforme lymphoproliferative disorder||Disease|| || || || || ||SP||
| ||
|-
|-
| Littoral cell angioma || Disease || || || || || || SP || ||
|Systemic chronic active EBV disease||Disease|| || || || || ||SP||
| ||
|-
|-
| Splenic hamartoma || Disease || || || || || || SP || ||
|Systemic EBV-positive T-cell lymphoma of childhood||Disease||*Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA|| || || || ||SP||
| ||
|-
|-
| Sclerosing angiomatoid nodular transformation (SANT) of spleen || Disease || || || || || || SP || ||
|Follicular dendritic cell sarcoma||Disease||Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG|| || || || ||SP||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma || Disease || || || || || || YA || ||
|EBV-positive inflammatory follicular dendritic cell sarcoma||Disease|| || || || || ||SP||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy || Disease || Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG || || || || || YA || ||
|Fibroblastic reticular cell tumour||Disease|| || || || || ||SP||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma with hypodiploidy || Disease || Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG || || || || || YA || ||
|Intranodal palisaded myofibroblastoma||Disease|| || || || || ||SP||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma with iAMP21 || Disease || Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte || || || || || YA || ||
|Littoral cell angioma||Disease|| || || || || ||SP||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion || Disease || Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG || || || || || YA || ||
|Splenic hamartoma||Disease|| || || || || ||SP||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features || Disease || Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine || || || || || YA || ||
|Sclerosing angiomatoid nodular transformation (SANT) of spleen||Disease|| || || || || ||SP||
| ||
|-
|-
| B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement || Disease || Yassmine Akkari Nicolas Millan || || || || || YA || ||
|B-lymphoblastic leukaemia/lymphoma||Disease|| || || || || ||YA||
| ||
|-
|-
| B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion || Disease || Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma || || || || || YA || ||
|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy||Disease||Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG|| || || || ||YA||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features || Disease || || || || || || YA || ||
|B-lymphoblastic leukaemia/lymphoma with hypodiploidy||Disease||Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG|| || || || ||YA||
| ||
|-
|-
| B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion || Disease || Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO || || || || || YA || ||
|B-lymphoblastic leukaemia/lymphoma with iAMP21||Disease||Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte|| || || || ||YA||
| ||
|-
|-
| B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion || Disease || Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO || || || || || YA || ||
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion||Disease||Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG|| || || || ||YA||
| ||
|-
|-
| B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion || Disease || || || || || || YA || ||
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features||Disease||Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine|| || || || ||YA||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations || Disease || || || || || || YA || ||
|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement||Disease||Yassmine Akkari Nicolas Millan|| || || || ||YA||
| ||
|-
|-
| B-lymphoblastic leukaemia/lymphoma, NOS || Disease || || || || || || YA || ||
|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion||Disease||Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma|| || || || ||YA||
| ||
|-
|-
| T-lymphoblastic leukaemia / lymphoma, NOS || Disease || || || || || || YA || ||
|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features||Disease|| || || || || ||YA||
| ||
|-
|-
| Early T-precursor lymphoblastic leukaemia / lymphoma || Disease || Fei Yang, MD, FACMG, Kaiser Permanente Northwest || || || || || YA || ||
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion||Disease||Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO|| || || || ||YA||
| ||
|-
|-
| Fanconi anaemia || Disease || || || || || || NA || ||
|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion||Disease||Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO|| || || || ||YA||
| ||
|-
|-
| Bloom syndrome || Disease || || || || || || NA || ||
|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion||Disease|| || || || || ||YA||
| ||
|-
|-
| Ataxia-telangiectasia syndrome || Disease || || || || || || NA || ||
|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations||Disease|| || || || || ||YA||
| ||
|-
|-
| RASopathies || Disease || || || || || || NA || ||
|B-lymphoblastic leukaemia/lymphoma, NOS||Disease|| || || || || ||YA||
| ||
|-
|T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||YA||
| ||
|-
|Early T-precursor lymphoblastic leukaemia / lymphoma||Disease||Fei Yang, MD, FACMG, Kaiser Permanente Northwest|| || || || ||YA||
| ||
|-
|Fanconi anaemia||Disease|| || || || || ||NA||
| ||
|-
|Bloom syndrome||Disease|| || || || || ||NA||
| ||
|-
|Ataxia-telangiectasia syndrome||Disease|| || || || || ||NA||
| ||
|-
|RASopathies||Disease|| || || || || ||NA||
| ||
|}
|}